Aim: The purpose of this study is to determine the long-term prognostic implications of incidental pleural effusion (PE) detected during echocardiographic examination and its relationship with concomitant diseases. Methods: The study was performed by evaluating patient (n¼251) records in whom PE was incidentally detected during echocardiographic examination in a tertiary hospital between 1999-2012. The patients were classified according to the concomitant primary diseases into four major groups; cardiovascular diseases, malignity, renal dysfunction and pulmonary diseases. The total lifetime is obtained from hospital records for patients died at hospital and social security institution records for patients having out-of-hospital death. Results: Prognostic data of PE according to concomitant illness are as follows: For those PE concomitant with heart failure (n¼151) patients life expectancies for one-year was 81% and five-year was 70%. For patients with malignancies (n¼45) life expectancies for one-year was 53% and five-year was 44%. For patients with pulmonary diseases (n¼37) life expectancies for one-year was 89% and five-year was 78%. For patients with renal diseases (n¼18) life expectancies for one-year was 100% and five-year was 83%. Except PE associated with malignancies others PE concomitant with heart failure, renal disease, and pulmonary disease have similar (p>0.05 for all) and favorable outcome than PE concomitant with malignancies (p<0.001). Conclusion: The prognosis of incidental diagnosis of PE by echocardiography is the worst for concomitant with malignancies, however, PE associated with non-malignant diseases including heart failure, pulmonary and renal diseases have similar and favorable outcome. Tuesday, October 29, 2013, 10:15 AM-11:30 Purpose: Cardiovascular diseases are the leading cause of death in patients with nonalcoholic steatohepatitis (NASH). In this study we aimed to investigate whether levels of liver enzymes may reflect severity of endothelial dysfunction in patients with NASH.
Epidemiology
Methods: Fifty patients with NASH diagnosed by liver biopsy and 30 healthy controls were included in this study. Fasting blood samples were obtained for measurement of glucose, insulin, cholesterol, triglyceride and liver ensymes. All patients underwent transthoracic echocardiography, brachial artery and carotid artery Doppler ultrasonography to evaluate flow mediated dilatation (FMD) and carotid artery intima-media thickness (CIMT). Results: Patients with NASH had impaired FMD (4.9AE2.8 % to 9.3AE4.4 %, p<0.001) and higher CIMT (0.79AE0.16 mm to 0.64AE0.11 mm, p<0.001) when compared with healty controls. Linear regression analyses revealed that levels of gamma glutamyl transferase (GGT) and alanine transaminase (ALT) were significantly associated with FMD and CIMT. Conclusions: Patients with NASH have impaired FMD and increased CIMT when compared with healty controls. In patients with NASH, levels of GGT and ALT might have predictive value for FMD and CIMT. 
